RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT)
RBC Capital Sticks to Its Buy Rating for Abbott Laboratories (ABT) The Globe and Mail
Covered in this story
What has happened since
- Abbott Laboratories is down 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $RBC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on RBC Bearings →Summary aggregated from The Globe and Mail's public RSS feed. The full reporting belongs to The Globe and Mail — please read it on their site.